Iomeron

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intra‑arterial and intravenous use. It enhances radiographic visibility of vascular structures and organs during imaging procedures, aiding diagnosis in both adult and pediatric patients as directed by a physician.

GNH USA supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Iomeron is used in radiographic procedures that require enhanced vascular and organ visualization. - Contrast‑enhanced X‑ray imaging: Improves delineation of blood vessels and soft‑tissue structures. - CT angiography: Provides high‑contrast detail of arterial and venous anatomy for diagnostic assessment. - Digital subtraction angiography: Enhances subtraction images for precise vascular mapping. - Contrast‑enhanced CT scans: Increases organ and lesion conspicuity for accurate interpretation.

Adverse reactions may occur following administration of iodinated contrast agents.

Common Side Effects: - Warmth or flushing sensation at the injection site. - Transient metallic taste in the mouth. - Mild nausea or vomiting. - Headache or mild dizziness.

Serious or Rare Side Effects: - Anaphylactoid or severe allergic reaction, including bronchospasm. - Contrast‑induced nephropathy leading to acute kidney injury. - Severe hypotension or cardiovascular collapse. - Cardiac arrhythmias. - Seizures or neurologic disturbances.

Proper patient assessment and monitoring are essential when using Iomeron. - Renal function assessment: Evaluate serum creatinine and eGFR before administration. - Allergy history: Confirm no prior severe reactions to iodinated contrast. - Hydration status: Ensure adequate patient hydration to reduce nephrotoxicity risk. - Concomitant nephrotoxic drugs: Use caution or discontinue if possible. - Store at ambient temperature: Keep in original container, protect from moisture and direct sunlight.

Iomeron may interact with other medications that affect renal function or iodine metabolism.

Major Interactions (Avoid): - Metformin: Risk of lactic acidosis; consider temporary discontinuation. - Nephrotoxic agents (e.g., aminoglycosides, NSAIDs): May exacerbate renal injury. - Concurrent iodinated contrast agents: Increases cumulative iodine load.

Moderate Interactions (Monitor Closely): - Beta‑blockers: May mask early signs of contrast reaction. - Thyroid hormone therapy: Excess iodine can alter thyroid function. - Diuretics: May affect renal clearance of the contrast medium.